Humana Inc (HUM · NYSE)

HUM · MARKET VIEW

Market view · as of Aug 31, 2026

Revenue (TTM)
$145.68B
+26.2% YoY
Gross margin
13.7%
EPS (latest q)
$7.61
vs $6.22 est · beat
52-wk position
90.3%
-5.8% vs 52w high · +6.0% 1mo

Price (last ~year)

Humana Inc. (HUM) has recorded a 26.2% year-over-year revenue increase to $145.68 billion TTM, exceeding analyst earnings estimates in each of the last four quarters, including a $7.61 per share result for the period ending June 30, 2026. Trading at $385.54 with a $46.30 billion market capitalization, the health insurer has recently seen multiple new institutional investments, including significant positions from Jupiter Topco LLC and Summit Street Capital Management.

Valuation

Market cap
$46.30B
P/E
37.18
PEG
2.224
P/B
2.454
P/S
0.318
Beta
0.74
Analyst target
$418.61

Quality & returns

Gross margin
13.7%
Operating margin
3.5%
Profit margin
0.9%
ROE
6.9%
ROA
3.9%

Price movement

Last
$385.54
1-month
+6.0%
3-month
+18.0%
RSI (14)
50
vs SMA200
+40.4%
52-wk position
90.3% -5.8% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-06-30$40.87B$1.36B$693.0M$1.31B
2026-03-31$39.65B$1.58B$1.19B$1.97B
2025-12-31$32.52B$-1.02B$-796.0M$-685.0M
2025-09-30$32.65B$108.0M$195.0M$480.0M

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots